| Literature DB >> 28636993 |
Wenzhi Guo1, Jiakai Zhang1, Dongyu Zhang2, Shengli Cao1, Gongquan Li1, Shuijun Zhang1, Zhihui Wang1, Peihao Wen1, Han Yang1, Xiaoyi Shi1, Jie Pan1, Hua Ye3.
Abstract
Hepatocellular carcinoma (HCC) ranks the sixth most common cancer and the third cause of cancer-related mortality worldwide. Recent studies identified that circ-ITCH Suppresses mutiple cancers proliferation via inhibiting the Wnt/beta-Catenin pathway. In current study, conducted a genetic association study together with epidemiological follow-up study to delineate the role of circ-ITCH in the development and progression of HCC. we found rs10485505 (adjusted OR =1.18; 95% CI=1.06-1.31; P value =3.1×10-3) and rs4911154 (adjusted OR =1.27; 95% CI=1.14-1.43; P value =3.7×10-5) were significantly associated with increased HCC risk. The expression level of circ-ITCH was significantly lower in HCC tissues, compared with that in adjacent tissues (P value < 0.001). Cox regression analysis indicated that high expression of circ-ITCH was associated with favorable survival of HCC (HR=0.45; 95% CI=0.29-0.68; P value < 0.001). These results indicate that circ-ITCH may have an inhibitory effect on HCC, and could serve as susceptibility and prognostic biomarkers for HCC patients.Entities:
Keywords: circ-ITCH; hepatocellular carcinoma; survival; susceptibility
Mesh:
Substances:
Year: 2017 PMID: 28636993 PMCID: PMC5564635 DOI: 10.18632/oncotarget.18327
Source DB: PubMed Journal: Oncotarget ISSN: 1949-2553
Demographic and epidemiological characteristics of the study population
| Variables | HCC (N=1800) | Controls (N=1800) | P value | ||
|---|---|---|---|---|---|
| N | % | N | % | ||
| Gerder | |||||
| Male | 1170 | 65.0 | 1215 | 67.5 | 0.113 |
| Female | 630 | 35.0 | 585 | 32.5 | |
| Age | |||||
| ≥55 | 1102 | 61.2 | 1089 | 60.5 | 0.657 |
| <55 | 698 | 38.8 | 711 | 39.5 | |
| HBV infection | |||||
| HBsAg + | 450 | 25.0 | 414 | 23.0 | 0.160 |
| HBsAg - | 1350 | 75.0 | 1386 | 77.0 | |
| Smoking status | |||||
| Ever | 369 | 20.5 | 360 | 20.0 | 0.709 |
| Never | 1431 | 79.5 | 1440 | 80.0 | |
| Alcohol status | |||||
| Ever | 540 | 30.0 | 396 | 22.0 | P<0.001 |
| Never | 1260 | 70.0 | 1404 | 78.0 | |
| Family history of cancer | |||||
| Yes | 99 | 5.5 | 18 | 1.0 | P<0.001 |
| No | 1701 | 94.5 | 1782 | 99.0 | |
| Education level | |||||
| <College degree | 1458 | 81.0 | 1431 | 79.5 | 0.258 |
| ≥College degree | 342 | 19.0 | 369 | 20.5 | |
Figure 1TagSNP selection of circ-ITCH
SNPinfo Web Server (https://snpinfo.niehs.nih.gov/) was used for the tagSNP selection of circ-ITCH.
Circ-ITCH genotypes and the risk of HCC
| Cases (N=1800) | Controls (N=1800) | OR (95% CIs) * | P trend | |
|---|---|---|---|---|
| rs6059851 | ||||
| GG | 640 (35.6%) | 600 (33.3%) | 1.00 (reference) | |
| GA | 878 (48.8%) | 870 (48.3%) | 1.04 (0.90-1.20) | |
| AA | 342 (19.0%) | 330 (18.4%) | 1.07 (0.89-1.29) | |
| A vs G | 1.04 (0.94-1.24) | 0.452 | ||
| rs6120663 | ||||
| CC | 1027 (57.1%) | 1035 (57.5%) | 1.00 (reference) | |
| AC | 685 (38.1%) | 673 (37.4%) | 1.02 (0.89-1.18) | |
| AA | 88 (4.9%) | 92 (5.1%) | 0.96 (0.71-1.31) | |
| A vs C | 1.01 (0.90-1.12) | 0.912 | ||
| CC | 1001 (55.6%) | 1083 (60.2%) | 1.00 (reference) | |
| CT | 689 (38.3%) | 632 (35.1%) | 1.18 (1.03-1.35) | |
| TT | 110 (6.1%) | 85 (4.7%) | 1.40 (1.04-1.88) | |
| T vs C | 1.18 (1.06-1.31) | 3.1×10-3 | ||
| GG | 1089 (60.5%) | 1200 (66.7%) | 1.00 (reference) | |
| GA | 632 (35.1%) | 550 (30.5%) | 1.27 (1.10-1.46) | |
| AA | 79 (4.4%) | 50 (2.8%) | 1.74 (1.21-2.49) | |
| A vs G | 1.27 (1.14-1.43) | 3.7×10-5 | ||
| rs7266300 | ||||
| AA | 1053 (58.5%) | 1002 (55.7%) | 1.00 (reference) | |
| AT | 665 (36.9%) | 699 (38.8%) | 0.90 (0.79-1.04) | |
| TT | 82 (4.6%) | 99 (5.5%) | 0.79 (0.58-1.07) | |
| T vs A | 0.90 (0.81-1.00) | 0.061 | ||
| rs11167234 | ||||
| TT | 819 (45.5%) | 820 (45.6%) | 1.00 (reference) | |
| TA | 783 (43.5%) | 775 (43.0%) | 1.01 (0.88-1.16) | |
| AA | 198 (11.0%) | 205 (11.4%) | 0.97 (0.78-1.20) | |
| A vs T | 0.99 (0.90-1.09) | 0.880 |
* Adjusted for age, gender, HBV infection, family history of cancer, smoking status, alcohol status, and education level.
Figure 2Comparison of circ-ITCH expression levels between HCC tissues and adjacent tissues
Mann–Whitney U-test was used to analyze the expression difference of circ-ITCH between HCC tissues and adjacent non-cancerous tissues.
Figure 3Prognostic value of circ-ITCH
Kaplan–Meier curves were utilized to assess the association between the circ-ITCH and overall survival of HCC patients.